Early phase clinical trials built for certainty
DVCR helps sponsors move from first-in-human through proof-of-concept with disciplined execution, responsive teams, integrated services and technology-enabled data quality.
Start the conversation
Share a few details and our team will follow up to discuss your study, timelines and operational requirements.
A full-service early phase CRO designed around execution
Early development programs depend on more than isolated services. DVCR brings a full suite of CRO services together to support reliable execution from startup through reporting.
Early phase focus
DVCR specializes in early phase clinical trials across a range of study designs, therapeutic areas and drug classes, with support from first-in-human through proof-of-concept.
Integrated CRO services
Project management, data management, biostatistics, statistical programming, PK/PD analysis and modeling, clinical and medical monitoring, medical writing as well as site feasibility, management and central laboratory services for Phase I-II multi-site trials with our global network of site partners.
Purpose-built Phase I infrastructure
A 100-bed Phase I unit, cGMP compliant pharmacy, in-house clinical laboratory and experienced recruitment model support complex early phase study conduct.
Exceptional responsiveness
Direct access to experienced study teams supports clear communication and aligned decision-making throughout the program lifecycle.
Team continuity
Consistent, early phase-focused teams preserve program knowledge, reduce handoff friction and provide stable ownership from startup through closeout.
Technology & innovation
Integrated eSource, EDC, barcode scanning, equipment integration and real-time sponsor access support cleaner data, greater visibility and audit-ready documentation.
Sponsor confidence in early phase execution
“The project managers, clinical monitors, investigators, entire clinical pharmacology unit team, medical monitor and data managers have years of experience with the management and conduct of early phase studies. I highly recommend DVCR.”
Support for common and complex early phase studies
DVCR supports a broad range of early phase study designs, including clinical pharmacology, specialized studies, healthy volunteers and patient populations and proof-of-concept programs.
- First-in-Human
- Single and Multiple Ascending Dose
- Drug-Drug Interaction
- Early QT/TQT Cardiac Assessments
- Pharmacokinetic/Pharmacodynamic
- Food Effect
- Proof-of-Concept
- Bioavailability/Bioequivalence
- Hepatic Impairment
- Renal Impairment
- Human Abuse Potential
- Patient Studies
- Phase I-II Multi-Site Trials
